<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04740736</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 19-1952</org_study_id>
    <nct_id>NCT04740736</nct_id>
  </id_info>
  <brief_title>Cardiovascular Analysis of PEM</brief_title>
  <official_title>Cardiovascular Analysis of Post-exertional Malaise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine cardiopulmonary function in Chronic Fatigue Syndrome&#xD;
      (CFS) patients and determine how it relates to the common symptom of Post-exertional malaise&#xD;
      (PEM). Subjects will complete a maximal exercise test on 2 subsequent days. Total blood&#xD;
      volume will be measured prior to each exercise test, and patient with hypovolemia on day 1,&#xD;
      will be randomized to either a saline or sham infusion prior to the 2nd exercise test. A&#xD;
      total of 80 CFS patients will be enrolled.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 31, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CPET testing</measure>
    <time_frame>2 days</time_frame>
    <description>To assess VO2VT and peak VO2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Blood Volume</measure>
    <time_frame>2 days</time_frame>
    <description>To measure Total Blood Volume (TBV) before each exercise test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hypovolemia</measure>
    <time_frame>1 day</time_frame>
    <description>Patients with reduced Total Blood Volume on day #1 CPET will be randomized in a 1:1 fashion to either a one hour infusion of a liter of isotonic saline prior to day #2 CPET or a sham infusion</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Myalgic Encephalomyelitis</condition>
  <condition>Chronic Fatigue Syndrome</condition>
  <arm_group>
    <arm_group_label>Saline Infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Infusion</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saline Infusion</intervention_name>
    <description>Patient with hypovolemia on day 1 will be randomized to a saline or sham infusion prior to the Day 2 exercise test.</description>
    <arm_group_label>Saline Infusion</arm_group_label>
    <arm_group_label>Sham Infusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ages 25 to 60&#xD;
&#xD;
          -  Meet the 2015 IOM case definition for ME/CFS&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a medical cause for their fatigue&#xD;
&#xD;
          -  Patients taking medications that would dampen cardiac response to exercise&#xD;
&#xD;
          -  Patients with psychotic illness, bipolar disorder, or current major depressive&#xD;
             disorder&#xD;
&#xD;
          -  Patients with a history of anorexia or bulimia within 5 years of intake&#xD;
&#xD;
          -  Patients with a history of alcohol or drug abuse within 2 years of intake&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Natelson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tiffany So</last_name>
    <phone>212-241-1438</phone>
    <email>tiffany.soto@mssm.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Benjamin Natelson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 2, 2021</study_first_submitted>
  <study_first_submitted_qc>February 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Benjamin Natelson</investigator_full_name>
    <investigator_title>Professor, Neurology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue Syndrome, Chronic</mesh_term>
    <mesh_term>Encephalomyelitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

